CJC 1295 is a synthetic peptide that promotes the increase of growth hormone and insulin growth factor levels, very similar to the growth hormone-releasing hormone (GHRH) in its function. Because of their similar functions, CJC 1295 may help with sleep, muscle growth, and fat loss.
According to an article in The Journal of Clinical Endocrinology & Metabolism , the research on this peptide suggested that it can potentially be used as a therapeutic agent. As more studies were conducted, researchers found  that this peptide offered more potential, particularly having a significantly positive effect on physical performance.
CJC 1295 Peptide Side Effects
Although this peptide has been studied for quite some time now, some researchers who are new to the field may wonder what kind of side effects this comes with. One of many studies, conducted in 2005 , stated that when subjects were administered the recommended dose, the peptide was well-tolerated and that no adverse reactions were reported.
This isn’t to say that no side effects ever occur. There have been reports of some minor side effects, particularly occurring at the injection site. Some of these side effects may include:
- Soreness and skin sensitivity
- Flushing of the skin
- Symptoms similar to the flu
What Is CJC 1295 With DAC?
The CJC 1295 peptide has recently been combined with a biological complex called DAC, and has thus undergone heavy lab testing to see what this new combination has to offer. DAC is an acronym for Drug Affinity Complex. This is an all new biochemical complex that, when bound with peptides, offers a wonderful advantage to the absorption and duration of peptides. Much of the lab testing of this new peptide blend is performed on rodents, but some studies have also tested the substance on canines.
What is the Half-Life of CJC 1295?
When administered on rats, research found  that DAC, when combined with CJC 1295 peptide, significantly increased the short half-life of CJC 1295 alone from an average of 30 minutes to about 7-8 days.
To clarify, the term “half-life” is how long it takes for the body’s concentration of a substance, drug or compound to be cut in half.
CJC 1295 With DAC vs No DAC
Many researchers who have been learning of this new combination are wondering whether they should stick with the CJC 1295 on its own since it is something they’re already familiar with, or give the new combination a shot. Hesitation is to be expected. Whether or not the CJC 1295 peptide is bound with DAC doesn’t really change its effects on the subjects. The only real difference is that CJC 1295 without DAC would not live and act as long as it would with DAC.
Thus, it can be inferred that the test subjects would require less frequent dosages. For example, instead of five injections per week, the frequency may be reduced to possibly two or three injections instead. This means less shots, syringes, money spent, and a better outcome. As a result, researchers could potentially save some money and avoid extra costs, because they would likely need less of this research peptide to create the same, yet longer lasting effect on their test subjects. In short, the advantage gained by researchers choosing to use CJC 1295 with DAC would outweigh the cost.
CJC 1295 DAC Dosage
This peptide usually comes in a vial containing either 2mg or 5mg of the peptide. In one study , the administered dose on test subjects was between 30 to 60 mcg/kg, twice a week. It is very important to note that, even for studies, researchers should not administer test subjects with more than the normal dose just mentioned, as this may lead to unanticipated, adverse reactions.
CJC 1295 Ipamorelin Blend
Similar to CJC 1295, Ipamorelin is a peptide that is considered to be the growth hormone releasing peptide, and its activation is more precise. By stimulating the pituitary gland, the Ipamorelin peptide helps increase the secretion of the growth hormone – leading to effects such as an increase in weight loss and lean muscle growth.
Since 1295 CJC and Ipamorelin are such similar peptides in their composition, function, and effect, it isn’t hard to imagine what research has uncovered about their potential when bonded together. The CJC 1295 Ipamorelin blend benefits may include but not limited to:
- accelerated weight loss and fat burn
- lean muscle growth
- increased cognitive health
- improvements of the immune system
Also, this CJC Ipamorelin blend has been shown to reduce blood sugar levels – a process which actually helps the subjects burn more fat and lose more weight.
Because of the potency and function of these two peptides, their combination produces a more powerful, consistent release of the human growth hormone. Because of this potent release, interesting and remarkable results are produced. The CJC 1295 Ipamorelin blend results included signs of the following:
- Anti-aging properties
- An increase in collagen and elastin levels (vital for skin health)
- Boosted lean muscle growth and repair
- Accelerated injury recovery, especially joint injuries
- Increased fat burn and weight loss
- Cognitive enhancements, especially in subjects with neurological diseases
Conclusion – Key Takeaways
CJC 1295 is a peptide that functions similarly to GHRH, which helps boost growth hormone levels. DAC is a biochemical complex that significantly increases the life of the peptide within the body, so going for CJC 1295 with DAC seems the more cost effective option when deciding to get CJC 1295 with or without DAC, though costs vary from seller to seller. Ipamorelin is a peptide similar in its function to CJC, but has been shown to be more accurately activated in the test subject. Hence, CJC 1295 blended with Ipamorelin offers a more potent, compounded effect, like faster fat loss, increase in muscle growth and repair, and even some anti-aging properties, just to name a few.
Buy Research Peptides Online
For top quality research peptides, visit our online store for a well curated selection of peptides such as buy CJC 1295 with DAC, and buy Ipamorelin, and CJC 1295 Ipamorelin blend.
NOTE: The information found on this website and within this article is intended for educational or informational purposes only. Some or all of the content in these articles are not substantiated by a medical professional and may be based on the opinions of the writer who may not be a medical or accredited professional. Not intended for personal or human use. Please review our Terms and Conditions before purchasing.
Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research.